PMDA drug package insert
セロクエル25mg錠
PMDA Prescription drug · LTLファーマ株式会社 · package insert Sep 8, 2026
Key facts
| Brand names | セロクエル25mg錠, セロクエル100mg錠, セロクエル200mg錠, セロクエル細粒50％ |
|---|---|
| Nonproprietary names | クエチアピンフマル酸塩 |
| Companies | 製造販売／LTLファーマ株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 抗精神病剤 |
| Therapeutic category codes | 871179 |
| YJ codes | 1179042F1020, 1179042F2026, 1179042F3022, 1179042C1023 |
| Approval numbers | 21200AMY00239, 21200AMY00240, 22100AMX02083, 21600AMZ00431 |
| Package insert edition | 第6版 |
| Package insert date | Sep 8, 2026 |
| PMDA document key | 171911_1179042C1023_3 |
| PMDA company code | 171911 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- 1–9 Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: